Literature DB >> 26752540

Biosimilar therapies in inflammatory bowel disease: should we care about patient profile?

Gionata Fiorino1, Maria Fazio2, Silvio Danese3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26752540     DOI： 10.1586/1744666X.2016.1141050

Source DB:  PubMed          Journal:  Expert Rev Clin Immunol        ISSN： 1744-666X            Impact factor:   4.473


× No keyword cloud information.
  3 in total

1.  Biosimilar Drugs for Inflammatory Bowel Disease: Is Similar Good Enough?

Authors:  Mariangela Allocca; Gionata Fiorino; Silvio Danese
Journal:  Dig Dis Sci       Date:  2017-11       Impact factor: 3.199

Review 2.  Anti-TNF Therapy in Crohn's Disease.

Authors:  Samuel O Adegbola; Kapil Sahnan; Janindra Warusavitarne; Ailsa Hart; Philip Tozer
Journal:  Int J Mol Sci       Date:  2018-07-31       Impact factor: 5.923

Review 3.  Recent Progress in the Diagnosis and Precise Nanocarrier-Mediated Therapy of Inflammatory Bowel Disease.

Authors:  Liucan Wang; Min Yu; Hua Yang
Journal:  J Inflamm Res       Date:  2021-04-29
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.